Gland Pharma Q3 Result: Net up 34% at Rs 273 cr
The Hyderabad-based drug maker had reported a profit after tax (PAT) of Rs 204 crore in the corresponding period of the previous fiscal.
Revenue from operations rose to Rs 1,063 crore in the October-December period of the current fiscal: PTI